Apolipoprotein M and Diabetic Retinopathy in 339 Type 2 Diabetes Patients

339 patients with type 2 diabetes mellitus were included in this cross-sectional study exploring the association between plasma apolipoprotein M (apoM) levels and diabetic retinopathy. The data, authored by Jin Ook Chung and last updated in April 2026, shows patients with diabetic retinopathy had significantly higher median plasma apoM levels (26.05 mg/L) than those without (21.47 mg/L). Logistic regression indicated a significant positive association between apoM levels and diabetic retinopathy after adjusting for confounders like age and HbA1c.

Use Cases

• Train predictive models for diabetic retinopathy risk based on plasma apolipoprotein M levels.
• Conduct statistical analysis on biomarker associations with diabetic complications.
• Validate clinical findings on apolipoprotein M's role in type 2 diabetes pathology.
• Perform exploratory data analysis on the relationship between biochemical markers and disease progression.

Strengths

• Includes data from 339 patients with type 2 diabetes mellitus.
• Provides specific median plasma apoM levels for groups with and without diabetic retinopathy.
• Statistical results, including odds ratios and confidence intervals, are reported in the description.

Limitations

• Row count and column-level documentation are unknown; field semantics must be inferred after download.
• The dataset is very small at 210.6 KB, indicating limited scope.
• Data may reflect bias inherent to the specific study population and methodology.

Provenance

Source

figshare

Collection Method

Cross-sectional clinical study.

Time Range

null

Freshness

Last updated 2026-04-13 04:35:28; freshness should be verified.

Geography

null